P

Piramal Pharma Ltd
NSE:PPLPHARMA

Watchlist Manager
Piramal Pharma Ltd
NSE:PPLPHARMA
Watchlist
Price: 220.2 INR -2.88% Market Closed
Market Cap: 290.8B INR
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

0
Revenue
+0%
Growth Rates:
1 Year
+117%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
0
Operating Income
+0%
Growth Rates:
1 Year
-15%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
0
Net Income
+0%
Growth Rates:
1 Year
-35%
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Earnings Waterfall
Piramal Pharma Ltd

Revenue
89.5B INR
Cost of Revenue
-32.9B INR
Gross Profit
56.6B INR
Operating Expenses
-45.4B INR
Operating Income
11.2B INR
Other Expenses
-10.8B INR
Net Income
389m INR

Income Statement
Piramal Pharma Ltd

Rotate your device to view
Income Statement
Currency: INR
Millions
Ones
Thousands
Millions
Billions
TTM
Quarterly
Annual
TTM
Mar-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024
Revenue
Revenue
70 816
N/A
41 222
-42%
81 712
+98%
64 621
-21%
87 038
+35%
89 495
+3%
Gross Profit
Cost of Revenue
(29 111)
(15 149)
(31 956)
(23 639)
(31 604)
(32 911)
Gross Profit
41 704
N/A
26 073
-37%
49 756
+91%
40 982
-18%
55 434
+35%
56 584
+2%
Operating Income
Operating Expenses
(30 196)
(12 820)
(34 250)
(26 640)
(38 971)
(45 365)
Selling, General & Administrative
(24 163)
(9 973)
(26 347)
(16 295)
(21 891)
(22 215)
Research & Development
(864)
0
(1 007)
0
0
0
Depreciation & Amortization
(6 767)
(3 707)
(7 406)
(5 670)
(7 592)
(7 697)
Other Operating Expenses
1 598
860
509
(4 675)
(9 488)
(15 453)
Operating Income
11 509
N/A
13 253
+15%
15 506
+17%
14 342
-8%
16 463
+15%
11 219
-32%
Pre-Tax Income
Interest Income Expense
585
(1 884)
1 053
(2 787)
(3 691)
(3 634)
Non-Reccuring Items
(70)
(323)
(628)
0
(628)
0
Gain/Loss on Disposition of Assets
(5)
0
(5)
0
0
0
Total Other Income
(13 221)
(9 903)
(14 134)
(9 537)
(8 926)
(3 892)
Pre-Tax Income
(1 202)
N/A
1 143
N/A
1 793
+57%
2 018
+13%
3 219
+60%
3 693
+15%
Net Income
Tax Provision
(663)
(540)
(1 615)
(1 790)
(2 766)
(3 304)
Income from Continuing Operations
(1 865)
602
178
227
453
389
Net Income (Common)
(1 865)
N/A
602
N/A
178
-70%
227
+28%
453
+99%
389
-14%
EPS (Diluted)
-1.53
N/A
0.47
N/A
0.14
-70%
0.17
+21%
0.34
+100%
0.31
-9%

See Also

Summary
PPLPHARMA intrinsic value, competitors valuation, and company profile.
DCF Valuation
PPLPHARMA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PPLPHARMA stock valuation using valuation multiples.
Wall Street Estimates
PPLPHARMA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PPLPHARMA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 241,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.